[email protected]

What you'll learn

Description: This course is designed to: Help Students and researcher to better understand Applied Pharmacotherapeutics with Latest treatment guidelines and best practices available in the world. Learning Outcome: 1. Understanding evidence based and Medication therapy management basic concepts 2. Latest Disease Treatment managements, Diagnosis, aetiology and pathophysiology as per national and International Standards

  • Overview about Medication therapy management Basic Concepts
  • a. Hypertension • (2024 European Society of Hypertension clinical practice guidelines • (Guideline-Driven Management of Hypertension An Evidence-Based Update: American Heart Association 2021, 2024 Updates) b. Angina and Myocardial Infarction • (2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) • (2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines)
  • a. Asthma (Global Initiative for Asthma GINA 2024 Guidelines: 2024 update of the Global Strategy for Asthma Management and Prevention) b. COPD (GOLD 2024 Guidelines: Global Initiative for Chronic obstructive lung diseases)
  • a. Diabetes (2024 Standards of Care in Diabetes (Standards of Care) includes all of current clinical practice recommendations of the American Diabetes Association (ADA) b. Thyroid Disorders Thyroid disease: assessment and management: 2023 NICE guideline
  • a. Tuberculosis (WHO 2021 and India TB Guidelines 2021) b. HIV/AIDs (WHO 2021 Guidelines HIV PREVENTION, TESTING, TREATMENT, SERVICE DELIVERY AND MONITORING) c. Urinary Tract Infection (2024 Guidelines by European Association of Urology Guidelines on Urological Infections)
  • Evidence Based Drug information Recourses and Software’s

Avatar
Dr. Kanav Khera
Professor

Working as Professor, Dept of Pharmacology/Pharmacy Practice, with more than 15 years of experience in Clinical Research/Biomedical Ethics/Evidence-based medicine, Antibiotic Stewardship program, pharmacovigilance, Drug Safety, Clinical trials, and outcome research. Dr Kanav Khera is also associate member secretory of Institutional ethics committee at School of Pharmaceutical Sciences, LPU. Dr Kanav Khera had vast experience in providing Pharmaceutical care services in Tertiary care hospitals and handling medication errors and related problems. Had published more than 35 research papers in National and international journals and was invited as a guest speaker at various events.